Feasibility of Left Ventricle Ejection Fraction Calculation Using Electrocardiographically Gated SPECT Acquisition of

Erik T Te Beek1, Albert Lafeber1, Jan W A Postema1

  • 1From the Departments of Nuclear Medicine.

Clinical Nuclear Medicine
|February 17, 2023
PubMed

Insights

Bone scintigraphy with electrocardiographically gated SPECT can assess left ventricular ejection fraction (LVEF) in cardiac amyloidosis. This method offers feasible LVEF estimations comparable to echocardiography.

Area of Science:

  • Nuclear Medicine
  • Cardiology
  • Cardiac Imaging

Background:

  • Cardiac amyloidosis is a progressive disease affecting heart function.
  • Accurate assessment of left ventricular ejection fraction (LVEF) is crucial for managing cardiac amyloidosis.

Purpose of the Study:

  • To evaluate the feasibility of analyzing left ventricle function using electrocardiographically gated SPECT during bone scintigraphy in patients with suspected cardiac amyloidosis.
  • To assess the accuracy of LVEF estimations derived from this technique compared to echocardiography.

Main Methods:

  • Bone scintigraphy was performed in 6 patients with suspected cardiac amyloidosis.
  • Electrocardiographically gated SPECT acquisition was added to assess left ventricle function.
  • LVEF was automatically determined from the gated SPECT data.

Main Results:

  • Cardiac-gated SPECT data showed adequate tracer uptake for myocardial contour determination.
  • LVEF estimations ranged from 24% to 54%.
  • LVEF measurements from gated SPECT generally showed small differences compared to prior echocardiography.

Conclusions:

  • Electrocardiographically gated SPECT acquisition during bone scintigraphy is feasible for LVEF analysis in cardiac amyloidosis.
  • This technique provides meaningful LVEF estimates that are comparable to echocardiography.
  • The method may help monitor disease progression or treatment response.

Related Concept Videos